Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age.

Scientific reports - 28 Sept 2022

Kotani Kiriko, Iwata Aya, Kukimoto Iwao, Nishio Eiji, Mitani Takeji, Tsukamoto Tetsuya, Ichikawa Ryoko, Nomura Hiroyuki, Fujii Takuma

Abstract excerpt

Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nomograms

Share to Papillomavirus Infections

Share to Probability

Share to Sensitivity and Specificity

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36171233
DOI: 10.1038/s41598-022-19722-3
PMCID: PMC9519568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age.PMID 36171233Read ↗

Performance of Nomogram Prediction Combining MiRNAs in Cervical Mucus, HPV Genotype and Age for Cervical Cancer and its Precursor LesionsSemantic proximity Read ↗

NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAsSemantic proximity Read ↗

Screening of Precancerous Lesions in Women with Human Papillomavirus (HPV) Infection by Molecular Typing and MicroRNA AnalysisSemantic proximity Read ↗

Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review).Semantic proximity Read ↗

Potential Biomarkers for Cervical Cancer Screening and TreatmentSemantic proximity Read ↗

Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.Semantic proximity Read ↗

Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.Semantic proximity Read ↗

The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.Semantic proximity Read ↗

Molecular markers for cervical cancer screeningSemantic proximity Read ↗

DNA methylation for cervical cancer screening: a training set in ChinaSemantic proximity Read ↗

Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.Semantic proximity Read ↗

The value of high-risk HPV E6/E7 mRNA test positivity with NILM cytology in detecting cervical squamous intraepithelial lesions and cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.